LEADER 02211nam  2200541   450 
001 9910792287603321
005 20230803024234.0
010   $a1-78084-282-1
035   $a(CKB)2560000000152111
035   $a(EBL)1179663
035   $a(SSID)ssj0001599943
035   $a(PQKBManifestationID)16306724
035   $a(PQKBTitleCode)TC0001599943
035   $a(PQKBWorkID)14892947
035   $a(PQKB)11550715
035   $a(MiAaPQ)EBC1179663
035   $a(Au-PeEL)EBL1179663
035   $a(OCoLC)876507115
035   $a(EXLCZ)992560000000152111
100   $a20220517d2013      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aPersonalized management of colorectal cancer /$feditors, Alfredo Falcone, Fotios Loupakis
205   $a1st ed.
210  1$aLondon, England :$cFuture Medicine Ltd.,$d[2013]
210  4$dİ2013
215   $a1 online resource (90 p.)
300   $aDescription based upon print version of record.
311   $a1-78084-284-8 
327   $aTitle page; Copyright page; Contents; Foreword. Personalized management of colorectal cancer; 1. Adjuvant treatment of stage II colon cancer: yes or no, what, when and why?; 2. Adjuvant treatment of stage III colon cancer: where are we and will we ever move forward?; 3. Challenges in the neoadjuvant treatment of rectal cancer ; 4. Molecular markers in radically resected colorectal cancer: from prognosis to prediction; 5. Liver-limited resectable stage IV: current reality and future perspectives; 6. Choosing the right biologic agent in the 'continuum-of-care era': a clinical perspective; Index
330   $aPersonalized Management of Colorectal Cancer 
606   $aColon (Anatomy)$xCancer$xTreatment
606   $aRectum$xCancer$xTreatment
615  0$aColon (Anatomy)$xCancer$xTreatment.
615  0$aRectum$xCancer$xTreatment.
676   $a616.994347
702   $aFalcone$b Alfredo
702   $aLoupakis$b Fotios
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910792287603321
996   $aPersonalized management of colorectal cancer$93851822
997   $aUNINA